Cytodyn Inc (CYDY)

[weasel6667]

On November 8, 2019, CytoDyn Inc. (the “Company”), issued in private placements to accredited investors an aggregate of 870 shares of its Series C
Convertible Preferred Stock, par value $0.001 per share, with an initial stated value of $1,000 per share (the “Series C Preferred Stock”), together with
warrants to purchase an aggregate of up to 2,175,000 shares of its common stock, par value $0.001 (“Common Stock”) per share, with an initial exercise
price of $0.30 per share (the “Series C Warrants”) for aggregate gross proceeds to the Company of approximately $0.9 million (the “Series C Offering”)

Link
870 shares?